Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

Press releases published on August 3, 2026

25 minutes ago

Veritasium Goes Behind the Scenes at Kraig Biocraft Laboratories to Explore the Future of Commercial Spider Silk

Indeterminate GlobeNewswire

30 minutes ago

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

Indeterminate GlobeNewswire

30 minutes ago

Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

30 minutes ago

Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

Indeterminate GlobeNewswire

30 minutes ago

Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia

Indeterminate GlobeNewswire

30 minutes ago

Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

30 minutes ago

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

Indeterminate GlobeNewswire

30 minutes ago

Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease

Indeterminate GlobeNewswire

30 minutes ago

Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.

Indeterminate GlobeNewswire

30 minutes ago

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

Indeterminate GlobeNewswire

40 minutes ago

Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026

Indeterminate GlobeNewswire

an hour ago

Supernus Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

Indeterminate GlobeNewswire

an hour ago

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

Indeterminate GlobeNewswire

3 hours ago

BioNTech ernennt Dr. Guido Oelkers zum neuen Vorstandsvorsitzenden

Indeterminate GlobeNewswire

3 hours ago

BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer

Indeterminate GlobeNewswire

3 hours ago

Interim Results from a Clinical Study Evaluating the Impact of Virtual Lactation Support through SimpliFed on Maternal Health and Breastfeeding Success Outcomes Released at Pediatrics Academic Societies Conference

Indeterminate GlobeNewswire

3 hours ago

NRG Therapeutics Announces the Appointment of Claus Sundgreen M.D. as Chief Medical Officer

Indeterminate GlobeNewswire

4 hours ago

Aravax Awarded FDA Fast Track Designation for PVX108, a Next-Generation Immunotherapy for the Treatment of Peanut Allergy

Indeterminate GlobeNewswire

4 hours ago

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

Indeterminate GlobeNewswire